A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Kivu Bioscience Inc.
Kivu Bioscience Inc.
Novartis
ViroMissile, Inc.
MacroGenics
Avacta Life Sciences Ltd
City of Hope Medical Center
University of Southern California
Actym Therapeutics, Inc.
M.D. Anderson Cancer Center
Valo Therapeutics Oy
Eli Lilly and Company
GONGCHU Biotechnology Co., Ltd
Jonsson Comprehensive Cancer Center
Baylor College of Medicine
German Cancer Research Center
National Cancer Institute (NCI)
BeiGene
Shanghai PerHum Therapeutics Co., Ltd.
Xencor, Inc.
Prelude Therapeutics
Gene Surgery LLC
DNAtrix, Inc.
National Cancer Institute (NCI)
Corvus Pharmaceuticals, Inc.
Prelude Therapeutics
Emory University
Tempest Therapeutics
Pfizer
Prelude Therapeutics
Quadriga Biosciences, Inc.
Genzada Pharmaceuticals USA, Inc.
Ludwig Institute for Cancer Research
Philogen S.p.A.
MacroGenics
The University of Texas Health Science Center, Houston
Seagen Inc.
Celgene
Tocagen Inc.
National Institutes of Health Clinical Center (CC)
CytoMed Therapeutics Pte Ltd
Virginia Commonwealth University
Merrimack Pharmaceuticals
University Health Network, Toronto
Corcept Therapeutics
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
GlaxoSmithKline
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)